Kevin Dalton
Equibles does not estimate personal net worth.
About Kevin Dalton
Iterum Therapeutics plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Iterum Therapeutics plc includes Brenton K. Ahrens (Chairman), David Kelly (Chairman), Beth Hecht (Board Member) and 6 others.
Affiliation history
-
Iterum Therapeutics plc (ITRMF)
Source not stated
Current
Company network
Leadership on record at Iterum Therapeutics plc
- Brenton K. Ahrens Chairman
- David Kelly Chairman
- Beth Hecht Board Member
- Beth P. Hecht Board Member
- Corey Fishman Board Member
- David G. Kelly Board Member
- Joseph J. Whalen Board Member
- Michael Dunne, M.D. Board Member
- Michael W. Dunne Board Member
Recent activity
No call appearances or filed executive changes recorded yet.